EWTX Edgewise Therapeutics, Inc.
Healthcare$33.16+0.00%OpenMarket Cap: $3.57B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$42.00
Target (Median)
$45.50
Target Range
$25.00 - $52.00
Upside from current price: 26.7%
Rating Distribution
3 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-17 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-17 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-27 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2025-11-14 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-07 | RBC Capital | maintain | Outperform | Outperform |
| 2025-11-07 | Wedbush | maintain | Outperform | Outperform |
| 2025-08-19 | JP Morgan | maintain | Overweight | Overweight |
| 2025-08-08 | RBC Capital | maintain | Outperform | Outperform |
| 2025-06-05 | RBC Capital | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.28 | $14.5M | 9 |
| Sun Dec 31 | $-1.70 | $127.5M | 8 |
| Mon Dec 31 | $-0.72 | $330.3M | 6 |
| Tue Dec 31 | $1.16 | $745.0M | 6 |